New research from scientists at the Marshall University Joan C. Edwards School of Medicine reveals that certain gut microbial byproducts may hold promise as a novel therapy for obesity-associated metabolic complications by restoring critical hormone-producing cells in the intestine.
The study, published this month in the International Journal of Molecular Sciences, focuses on enteroendocrine cells (EECs)-specialized cells in the gut that play a key role in metabolic regulation by releasing hormones such as glucagon-like peptide-1 (GLP-1), which stimulate insulin secretion and suppress appetite. In obesity, these cells are diminished in number and function, contributing to insulin resistance and poor metabolic…
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We 5guruayurveda.com want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Website Upgradation is going on. For any glitch kindly connect at 5guruayurveda.com
